This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Dow (DOW) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not show that Dow (DOW) is likely to beat the Zacks Consensus Estimate this quarter.
Harvey Cripples Packaging Industry, Dump These Stocks
by Zacks Equity Research
As Harvey wreaked havoc on Texas, it had a domino effect on the packaging industry as chemical production was disrupted that led to increase in prices of the raw materials used by the industry.
Monsanto's Tech Improvements to Boost Innovation Platform
by Zacks Equity Research
Monsanto (MON) offers advanced Climate FieldView platform and NemaStrike technology for 2018 crop season. It intends to supply more Roundup Ready 2 Xtend soybeans in the United States.
Dow Chemical, TeselaGen Team Up to Expand Biodesign Platform
by Zacks Equity Research
Dow Chemical's (DOW) fully owned subsidiary Dow AgroSciences and TeselaGen collaborates to produce a state-of-the-art biological design automation platform that can expedite discovery work.
Dow, Saudi Aramco to Restructure Ownership in Sadara JV
by Zacks Equity Research
The potential ownership restructuring would increase Dow Chemical's (DOW) equity stake in Sadara JV to 50%.
DuPont to Exhibit Food Solutions Addressing Health Issues
by Zacks Equity Research
DuPont (DD) has come up with local food solutions that will be introduced at Food Ingredients Asia 2017 in response to health and nutrition concerns in Southeast Asia.
DuPont (DD) to Upgrade Probiotics Facility in Wisconsin
by Zacks Equity Research
DuPont's (DD) Nutrition & Health segment announced an expansion of its probiotics pilot facility in Madison, WI worth $10 million which will strengthen DuPont's position as a leading player in the probiotics industry.
Trump Passes Order to Fix U.S. Infrastructure: ETFs in Focus
by Zacks Equity Research
President Trump rolls back environmental policies in order to expedite Infrastructure projects.
Monsanto (MON) Signs Deal with ToolGen for CRISPR Technology
by Zacks Equity Research
Monsanto Company (MON) enhances genome-editing tools portfolio by signing a deal with ToolGen, in order to secure intellectual property rights for the latter's CRISPR technology.
Dow Chemical, Saudi Aramco JV Sadara Commissions Last Plant
by Zacks Equity Research
Dow Chemical's (DOW) Sadara joint venture in Saudi Arabia has commissioned its last plant, the region's first isocyanates facility.
Dow Chemical's (DOW) New $100M Center to Focus on Innovation
by Zacks Equity Research
Dow Chemical's (DOW) new $100 million innovation center will drive innovation and create growth synergies at intersection of organic chemistry and silicone science.
DuPont's Granular Buyout to Drive Profits for Farmers
by Zacks Equity Research
DuPont (DD) signs a definitive agreement to purchase Granular with an objective to help farmers operate more profitable businesses.
Dow Chemical, Arcadia Tie Up to Develop Wheat Traits
by Zacks Equity Research
Dow Chemical's (DOW) unit Dow AgroSciences and Arcadia Biosciences collaborate to develop and commercialize improved wheat quality trait in North America.
Dow Chemical, DuPont Set Date for Merger Completion
by Zacks Equity Research
The mega-merger of Dow Chemical (DOW) and DuPont is set to close on Aug 31.
Dow Chemical's (DOW) Q2 Earnings & Sales Trump Estimates
by Zacks Equity Research
Cost cuts and improved pricing help Dow Chemical (DOW) top earnings expectations in the second quarter.
Dow Chemical (DOW) Tops Q2 Earnings & Sales Estimates
by Zacks Equity Research
Dow Chemical's (DOW) second-quarter adjusted earnings and sales beat the respective Zacks Consensus Estimate.
Chemical Stock Q2 Earnings Slated on Jul 27: DOW, EMN & More
by Zacks Equity Research
The chemical industry's momentum is expected to continue in Q2 on continued strength across major end-use markets.
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Syngenta, Albemarle and Monsanto
by Zacks Equity Research
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Syngenta, Albemarle and Monsanto
Dow Chemical (DOW) Q2 Earnings Preview: Will it Disappoint?
by Zacks Equity Research
Weak agriculture demand and higher feedstock and maintenance costs may hurt Dow's (DOW) second-quarter earnings.
DuPont's (DD) Q2 Earnings & Revenues Trounce Estimates
by Zacks Equity Research
Strong volume gains and strength in agriculture help DuPont (DD) top earnings expectations in the second quarter.
Q2 Earnings From GOOGL,MCD,CAT And More
by Zacks Equity Research
Q2 Earnings From GOOGL,MCD,CAT And More
Q2 Earnings Ball Keeps Rolling: MCD, CAT, MMM & More
by Mark Vickery
Following GOOGL's miss yesterday, Q2 earnings season does not pump the breaks; it keeps going, with several Dow components having reported before the bell today.
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Eastman Chemical, Celanese and Air Products
by Zacks Equity Research
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Eastman Chemical, Celanese and Air Products
Chemicals Industry Stock Outlook - July 2017
by Zacks Equity Research
The highly cyclical industry is finally finding traction again after bearing the brunt of the global economic crisis.
DuPont (DD) Warms Up to Q2: Another Earnings Beat Coming?
by Zacks Equity Research
DuPont's (DD) cost-saving and productivity measures coupled with strong demand for new products should continue to lend support to its earnings in the second quarter.